Network Biology-Inspired Machine Learning Features Predict Cancer Gene Targets and Reveal Target Coordinating Mechanisms.

gene dependency systems biology systems pharmacology

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
16 May 2023
Historique:
received: 03 04 2023
revised: 08 05 2023
accepted: 11 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Anticipating and understanding cancers' need for specific gene activities is key for novel therapeutic development. Here we utilized DepMap, a cancer gene dependency screen, to demonstrate that machine learning combined with network biology can produce robust algorithms that both predict what genes a cancer is dependent on and what network features coordinate such gene dependencies. Using network topology and biological annotations, we constructed four groups of novel engineered machine learning features that produced high accuracies when predicting binary gene dependencies. We found that in all examined cancer types, F1 scores were greater than 0.90, and model accuracy remained robust under multiple hyperparameter tests. We then deconstructed these models to identify tumor type-specific coordinators of gene dependency and identified that in certain cancers, such as thyroid and kidney, tumors' dependencies are highly predicted by gene connectivity. In contrast, other histologies relied on pathway-based features such as lung, where gene dependencies were highly predictive by associations with cell death pathway genes. In sum, we show that biologically informed network features can be a valuable and robust addition to predictive pharmacology models while simultaneously providing mechanistic insights.

Identifiants

pubmed: 37242535
pii: ph16050752
doi: 10.3390/ph16050752
pmc: PMC10223789
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : P30CA015083
Pays : United States
Organisme : NIH HHS
ID : R01AG056318, P50CA136393, R01AG61796, R03OD34496-1, CA240323, GM065841-16
Pays : United States

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Nat Commun. 2019 Dec 20;10(1):5817
pubmed: 31862961
BMC Syst Biol. 2018 Jul 31;12(1):80
pubmed: 30064421
Oncogene. 2014 Jul 24;33(30):3927-38
pubmed: 23995784
Nat Commun. 2020 Oct 30;11(1):5485
pubmed: 33127883
Mol Syst Biol. 2007;3:140
pubmed: 17940530
Gut. 2022 Apr;71(4):665-675
pubmed: 33789967
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Front Genet. 2020 Feb 05;11:29
pubmed: 32117445
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Cancer Cell Int. 2021 Oct 12;21(1):530
pubmed: 34641874
Int J Mol Sci. 2021 Nov 15;22(22):
pubmed: 34830205
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Genome Biol. 2021 Dec 20;22(1):343
pubmed: 34930405
Genes (Basel). 2019 Feb 14;10(2):
pubmed: 30769902
Nat Rev Cancer. 2018 Nov;18(11):696-705
pubmed: 30293088
Nat Commun. 2016 Feb 01;7:10331
pubmed: 26831545
PLoS Comput Biol. 2013;9(3):e1002975
pubmed: 23555212
BMC Bioinformatics. 2006 Mar 20;7 Suppl 1:S7
pubmed: 16723010
Cell Syst. 2022 Sep 21;13(9):690-710.e17
pubmed: 35981544
BMC Bioinformatics. 2017 Jan 5;18(1):18
pubmed: 28056782
J Bioinform Syst Biol. 2021;4(1):13-32
pubmed: 33842927
Bioinformatics. 2021 Sep 9;37(17):2675-2681
pubmed: 34042953
J Transl Med. 2012 Oct 03;10:205
pubmed: 23034130
Curr Opin Pharmacol. 2020 Apr;51:78-92
pubmed: 31982325
Sci Adv. 2021 Aug 20;7(34):
pubmed: 34417181
Nat Cancer. 2022 Jun;3(6):681-695
pubmed: 35437317
Sci Rep. 2021 Jun 23;11(1):13154
pubmed: 34162989
Nat Genet. 2021 Dec;53(12):1664-1672
pubmed: 34857952
Biomedicines. 2021 Feb 09;9(2):
pubmed: 33572373
Mol Cell Proteomics. 2009 Apr;8(4):827-45
pubmed: 19098285
Genes Chromosomes Cancer. 2022 Nov;61(11):670-677
pubmed: 35672279
Genome Res. 2022 Jan;32(1):124-134
pubmed: 34876496
Nature. 2001 May 3;411(6833):41-2
pubmed: 11333967
Cell. 2017 Jul 27;170(3):577-592.e10
pubmed: 28753431

Auteurs

Taylor M Weiskittel (TM)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Mayo Clinic Alix School of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Andrew Cao (A)

Department of Computer Science, Duke University, Durham, NC 27708, USA.

Kevin Meng-Lin (K)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Zachary Lehmann (Z)

Department of Chemistry, Biochemistry and Physics, South Dakota State University, Brookings, SD 57006, USA.

Benjamin Feng (B)

Department of Molecular Cell and Developmental Biology, University of California, Los Angeles, CA 90095, USA.

Cristina Correia (C)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Cheng Zhang (C)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Philip Wisniewski (P)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Shizhen Zhu (S)

Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Choong Yong Ung (C)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Hu Li (H)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.

Classifications MeSH